TY - JOUR
T1 - Rate and maintenance of improvement of myofascial pain with dry needling alone vs. dry needling with intramuscular electrical stimulation
T2 - a randomized controlled trial
AU - Brennan, Kindyle
AU - Elifritz, Katherine M.
AU - Comire, Megan M.
AU - Jupiter, Daniel C.
N1 - Publisher Copyright:
© 2020 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2021
Y1 - 2021
N2 - Study design: Prospective, randomized Objectives: To determine the difference in rate and maintenance of improvement of pain and disability for Dry Needling (DN) compared to Dry Needling with Intramuscular Electrical Stimulation (DN/IMES), in Myofascial Pain Syndrome (MPS). Background: DN and neuromuscular electrical stimulation (NMES) have been shown to be efficacious in treating MPS. DN/IMES for MPS treatment has not been studied extensively, but initial results are promising. Methods: Forty-five subjects were randomly assigned to the DN (n = 25) or DN/IMES (n = 20) group. Both groups received six consecutive weekly treatments and completed NDI and NPRS questionnaires (week 0, 3, 6, and 12). Results: Both DN and DN/IMES groups showed significant improvement between weeks 0–6 on NDI (p = 0.008 and 0.00002, respectively) and NPRS scores (0 = 0.017 and p = 0.018, respectively). DN/IMES group showed significant within group changes on the NPRS between weeks 0–3 (p = 0.029). No changes were noted in the DN or DN/IMES groups between week 6–12 on NDI (p = 0.497 and p = 0.714, respectively) or NPRS (p = 0.801 and p = 0.164, respectively). Conclusion: DN and DN/IMES demonstrated improvement and maintenance in disability and pain for 6 weeks. No differences in improvement of disability or pain existed between the groups at week 6 or 12.
AB - Study design: Prospective, randomized Objectives: To determine the difference in rate and maintenance of improvement of pain and disability for Dry Needling (DN) compared to Dry Needling with Intramuscular Electrical Stimulation (DN/IMES), in Myofascial Pain Syndrome (MPS). Background: DN and neuromuscular electrical stimulation (NMES) have been shown to be efficacious in treating MPS. DN/IMES for MPS treatment has not been studied extensively, but initial results are promising. Methods: Forty-five subjects were randomly assigned to the DN (n = 25) or DN/IMES (n = 20) group. Both groups received six consecutive weekly treatments and completed NDI and NPRS questionnaires (week 0, 3, 6, and 12). Results: Both DN and DN/IMES groups showed significant improvement between weeks 0–6 on NDI (p = 0.008 and 0.00002, respectively) and NPRS scores (0 = 0.017 and p = 0.018, respectively). DN/IMES group showed significant within group changes on the NPRS between weeks 0–3 (p = 0.029). No changes were noted in the DN or DN/IMES groups between week 6–12 on NDI (p = 0.497 and p = 0.714, respectively) or NPRS (p = 0.801 and p = 0.164, respectively). Conclusion: DN and DN/IMES demonstrated improvement and maintenance in disability and pain for 6 weeks. No differences in improvement of disability or pain existed between the groups at week 6 or 12.
KW - Trigger point dry needling
KW - neck Pain
KW - shoulder pain
KW - upper trapezius
UR - http://www.scopus.com/inward/record.url?scp=85091779888&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091779888&partnerID=8YFLogxK
U2 - 10.1080/10669817.2020.1824469
DO - 10.1080/10669817.2020.1824469
M3 - Article
C2 - 32990529
AN - SCOPUS:85091779888
SN - 1066-9817
VL - 29
SP - 216
EP - 226
JO - Journal of Manual and Manipulative Therapy
JF - Journal of Manual and Manipulative Therapy
IS - 4
ER -